Myopia Spectacle lenses

EssilorLuxottica has announced the US Food and Drug Administration (FDA) has granted market authorisation for its Essilor Stellest lens using...

HOYA Vision Care has launched a new breakthrough in lens technology, unveiling Smooth Touch Xtreme (STX) – its first top-coating...

Optometrists can prescribe MiYOSMART with even more confidence with HOYA revealing new eight-year data. No other clinical study on myopia...

HOYA Vision Care has announced new clinical evidence from three key clinical studies highlighting the impact of Defocus Incorporated Multiple...

The Essilor Stellest lens, clinically proven to slow myopia progression in children,^1 has now been evaluated in two studies for...

Insight has compiled a round-up of the main products available for myopia management in Australia in 2024, including some upgrades...

Melbourne lens manufacturer, CR Labs, is set to showcase the industry’s latest technological offerings to “advance the field of independent...

Managing myopia in children can be a different ball game in a public-facing clinic, opposed to those in a corporate,...

Ophthalmic equipment and lens company ZEISS is now offering a complete Kids Portfolio, comprising lenses that cater for the visual...

Australian-owned optical lens and equipment supplier Opticare has two new spectacle lens designs adopting the principle of peripheral retinal defocus...